Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Recs

0
Player Avatar davidm9999 (61.25) Submitted: 1/16/2012 4:10:38 PM : Underperform Start Price: $77.77 REGN Score: -65.40

Just popped, irrationally

Featured Broker Partners


Advertisement